Clinical Trial Keywords:
Diabetic Retinopathy, Age-Related Macular Degeneration
Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK et al and the Diabetic Retinopathy Clinical Research Network Study Group. Agreement Between Clinician and Reading Center Gradings of Diabetic Retinopathy Severity Level at Baseline in a Phase 2 Study of Intravitreal Bevacizumab for Diabetic Macular Edema. Retina 2008;28(1):36-404
Klein ML, Ferris FL, Armstrong J, Hwang T, Chew E, Bressler SB, Chandra SR and the AREDS Research Group: Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 2008;115(6):1026-1031.
Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ.Kim JE, Friedman SM, Qin H and the Diabetic Retinopathy Clinical Research Network: A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features. Retina 2008:28(7):919-930.
Diabetic Retinopathy Clinical Research Network. Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema. (Dr. S Bressler is a co-investigator in the DRCR.net) Ophthalmology 2008 Sep;115(9):1447-1459.e10
AREDS Report No. 23: The Relationship of Dietary w-3 Long-Chain Polyunsaturated Fatty Acid Intake with Incident Age-Related Macular Degeneration. (Dr. Susan Bressler is a member of the AREDS research group). Arch of Ophthal, 2008:126(9):1274-1279.
Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU and the Diabetic Retinopathy Clinical Research Network: Diabetic Macular Edema: What is focal and what is diffuse? Am J Ophthalmol 2008 Nov;146(5):649-55.
Solomon SD and Bressler SB: Increased Caucasian Prevalence of Medium and Large Drusen, Focal Pigment Abnormalities, and Advanced Age-related Macular Degeneration Relative to other Ethnic Groups. US Ophthalmic Review, .2008:(3)57-61.
Chew EY, Sperduto RD, Milton RC, Clemmons TE, Gensler GR, Bressler SB et al : Risk of Advanced Age-related Macular Degeneration Following Cataract Surgery in the Age-Related Eye Disease Study. AREDS Report 25. Ophthalmololgy 2009:116(2)297-303.
Glassman AR, Beck RW, Browning DJ, Danis RP, Kollman C, for the Diabetic Retinopathy Clinical Research Network Study Group: Comparison of Optical Coherence Tomography Retinal Thickness Measurements in Diabetic Macular Edema with and without Reading Center Manual Grading from a Clinical Trials Perspective. (Dr. Susan Bressler is a member of the DRCR.net) IOVS, 2009:20(2)560-566.
Diabetic Retinopathy Clinical Research Network: Three-year Followup of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema (Dr. Susan Bressler is a member of the DRCR.net). Arch Ophthalmol, 2009: 127(3)245-251
Sun JK, Aiello LP, Stockman M, et al. For the Diabetic RetinopathyClinical Research Network: Effects of Dilation on Electronic-ETDRS Visual Acuity (EVA) in Diabetic Patients (Dr. S Bressler is a member of The Network). Invest Ophthalmol Vis Sci. 2009: 50(4)1580-4.
Browning DJ, Apte RS, Bressler SB, et al and the Diabetic Retinopathy Clinical Research Network. Association of the Extent of Diabetic Macular Edema as Assessed by Optical Coherence Tomography with Visual Acuity and Retinal Outcome Variables. Retina. 2009;29(3):300-5.
Chang MA, Bressler SB: Photodynamic Therapy for Chronic Pigment Epithelial Detachment in Central Serous Chorioretinopathy. Canadian Journal of Ophthalmology, 2009;44(2)221-222
Scott IU, Danis RP, Bressler SB Bressler NM, Browning DJ, et al for the Diabetic Retinopathy Clinical Research Network: Effect of Focal/Grid Photocoagulation on Visual Acuity and Retinal Thickening in Eyes with Non-Center Involved Clinically Significant Diabetic Macular Edema. Retina 2009;29(5)613-617.
Bressler S, Melia M, Glassman A, Almukhtar T, Jampol L, et al for the Diabetic Retinopathy Clinical Research Network. Ranibizumab Plus Prompt or Deferred Laser for Diabetic Macular Edema in Eyes with Vitrectomy Prior to Anti-Vascular Endothelial Growth Factor Therapy. Retina, May 2015. DOI: 10.1097/IAE.0000000000000617.
The Diabetic Retinopathy Clinical Research Network. Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained IOP Elevation or Ocular Hypotensive Treatment. (Writing Committee: Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, et al). JAMA Ophthalmol. 2015;133(5):589-597.
Thomas M, Wolfson Y, Zayit-Soudry S, Bressler S, Bressler N: Qualifying to Use a Home Device to Monitor for Detection of Neovascular Age-related Macular Degeneration. In press JAMA Ophth 2015.
Mitchell P, Massin P, Bressler SB, Coon C, Petrillo J, et al. Three-Year Patient-Reported Visual Function Outcomes in Diabetic Macular Edema Managed with Ranibizumab: The RESTORE Extension Study. In press Current Medical Research and Opinion, 2015.
Bressler SB, Ayala A, Bressler NM, Melia M, Qin H, et al. for the Diabetic Retinopathy Clinical Research Network. An Exploratory Analysis of Persistent Macular Thickening Following Intravitreous Ranibizumab for Center-involved Diabetic Macular Edema with Vision Impairment. Submitted to JAMA Ophthalmol 2015.